Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

DEA Suspension of Distribution License

In June 2010, the U.S. Drug Enforcement Agency (DEA) temporarily suspended Harvard Drug Group’s license to distribute DEA-controlled substances and listed chemicals. A DEA investigation found several of Harvard Drug Group’s largest purchasers were illegally dispensing oxycodone, the generic name for the pain-killing drug OxyContin. The investigation revealed that Harvard Drug Group distributed over 13 million dosage units of oxycodone products to customers between March 2008 and March 2010. The DEA and Harvard Drug Group eventually reached an agreement to scale back the suspension as to certain classes of controlled substances.

Misconduct Type
Health
Enforcement Agency
Justice
Contracting Party
None
Court Type
Administrative
Disposition
Administrative Agreement
Date of Suspension Announcement
6/15/2010
Contractors Involved Penalty
Total
Court Square Capital Partners $0
Further Information Released
DEA Press Release 5/7/2011
Harvard Drug Group Press Releases 5/7/2011

Federal Contractor Misconduct Database